MiDAS

Related by string. Midas * * Misys Midas Plus . Jose Midas Marquez . Forbes Midas . Midas Muffler . column Midas . Midas touch . Midas Eyes . midas touch . Midas Marquez . Development Authority MIDA . spokesman Midas Marquez . Midas Touch . Midas Letter . Midas Mbabane City . Development Authority Mida . Midas List . Development Authority MiDA . proprietary MIDAS . Study MIDAS *

Related by context. Frequent words. (Click for all words.) 59 Phase Ib clinical 57 multicenter Phase 56 Patient Registry 56 Phase Ib II 56 Cardiac Imaging 54 Phase IIIb 54 Anticoagulation 54 PRECiSE 54 phase IIa clinical 54 Multicenter 54 Phase IIB 54 Patient Outcomes 54 phase IIa 53 placebo controlled clinical 53 phase Ib 53 placebo controlled Phase 53 Phase 2b study 53 Gastric Cancer 53 subanalysis 53 prospective multicenter 53 Natural Catastrophe Stress 53 Response Evaluation Criteria 53 bronchial thermoplasty 52 randomized multicenter 52 efficacy endpoint 52 phase IIb 52 pharmacokinetic PK 52 EVEREST II 52 Immunogenicity 52 APTIVUS 52 Thrombolysis 52 CALGB 52 MERLIN TIMI 52 NeuroStar TMS Therapy 52 EORTC 52 Chronic Heart Failure 52 multicenter clinical 52 Phase 1b clinical 52 Denufosol 52 relapsing multiple sclerosis 52 Phase 1b trial 52 Acute Myocardial Infarction 51 Meta Analysis 51 Arch Intern Med 51 II Clinical Trial 51 Phase 2a clinical 51 SYNTAX 51 secondary efficacy endpoints 51 LIALDA 51 prospective observational 50 Venous Thromboembolism 50 Randomized controlled 50 Am J Epidemiol 50 teriflunomide 50 TRITON TIMI 50 Percutaneous Coronary Intervention 50 Confirmatory 50 Phase 2a trial 50 pharmacokinetics PK 50 SABCS 50 SWOG 50 Gastrointestinal Cancers Symposium 50 AZOR 50 phase 2a 50 Radiation Therapy Oncology 50 prospective randomized controlled 50 Clinical Outcomes 50 Phase Ib 50 Rosuvastatin 50 ENVISION 50 NLX P# 50 Phase 2b trial 50 Phase IIa clinical 50 chemoradiotherapy 49 phase IIb clinical 49 Phase IIa trial 49 Childhood Asthma 49 Phase 2a 49 Diagnostic Tool 49 dose escalation trial 49 Metallurgical testwork 49 nonrandomized 49 PRECISE 49 NSABP 49 Phase 1b 49 sunitinib malate 48 placebo controlled studies 48 CQI 48 multicenter randomized 48 Phase 2b 48 Myocardial Infarction 48 PRADAXA 48 multicentre 48 unblinding 48 Phase IIb 48 DCCT 48 pertuzumab 48 double blinded placebo 48 immunohistochemical 48 Targeted Therapy 48 Phase IIa

Back to home page